Clinical Guidelines & Pathways


Crohn’s Disease -Moderate to Severe Disease Treatment Pathway


Approved by BLMK APC, March 2023, updated September 2023. Minor update Oct 2024 (to incorporate biosimilar ustekinumab)

View Document

Guideline Categories: Gastroenterology

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: biologic, biologic treatment, chron, chron's, crohn, crohn's, crohn's diease, crohns disease

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net